9 Healthcare Tech Startups To Watch - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Healthcare // Leadership
07:06 AM
Alison Diana
Alison Diana
Connect Directly

9 Healthcare Tech Startups To Watch

As venture capital flows into healthcare startups, look at some new companies that should be on your radar.
1 of 11

Investors poured billions of dollars into health technology startups in 2014, fueling companies that plan to reshape everything from clinical trials to analytics to payment processes.

In 2013, funding for digital health reached $2.83 billion across 578 deals, compared with $999 million for 139 deals in 2010, according to HIT Consultant. Digital health funding skyrocketed to $5.3 billion for the first three quarters of this year, HIT Consultant reported.

"There was over $400 million dollars of VC financing for mobile health in just the first quarter of the year," BridgeCrest CEO Nathan Klarer told InformationWeek.

All this healthcare money comes from multiple sources. Venture capital firms that invest in at least 10 healthcare companies and reap 50% or more of their deals in this vertical include OrbiMed Advisors, Alta Partners, Versant Ventures, SV Life Sciences, and VenBIO, while other VCs with broader investments continue to fuel medical-oriented technology firms. Healthcare organizations -- such as GE, Blue Cross/Blue Shield of Florida, and CVS -- are investing in startups, while mainstream technology businesses like Google and Apple are funneling money into young healthcare companies. Even regions are getting into the act, setting up investment hubs that spotlight healthcare startups in cities including Philadelphia, Boston, and Manhattan.

In December, McKesson launched McKesson Ventures "to invest in early- and growth-stage companies addressing both current and emerging business challenges facing the healthcare industry," the company said. Healthcare and life sciences captured more than one-third of Google Ventures' monies in 2014, compared with only 9% each in the past prior years, the Wall Street Journal reported.

The federal government is encouraging entrepreneurs to leverage its investment in new discoveries and devices. The Neuro Startup Challenge, sponsored by Heritage Provider Network and orchestrated by the Center for Advancing Innovation, encourages university scholars, private industry, entrepreneurs, and others to commercialize neuroscience inventions, said Bryan Sivak, chief technology officer at the US Department of Health and Human Services in an interview. Last year, the challenge focused on breast cancer.

"We believe this proven challenge framework creates a new pillar for HHS to impact human health by launching startups from promising HHS conceived and developed inventions," he said. "The challenge uses a novel model that gets tangible, expeditious, and efficient results; we hope to see this approach institutionalized across all federal labs."

Within one year the challenge has grown, Rosemarie Truman, founder and CEO of the Center for Advancing Aging, told InformationWeek. This year, 560 individuals competed in about 70 to 77 teams, compared with 476 in 2013, she noted, and of those, 70% focus on STEM while the remainder are serial entrepreneurs. The challenge includes creating an elevator speech and two-minute video, plus executive summary and crowdsourced feedback. Later stages -- which include fewer participants -- create a business plan and actually enter the startup phase, including finding funding and getting a National Institute of Health license.

Startup energies
Medical devices and equipment capture the biggest share of one group of investors' fortunes, reaping more than one-third of funds from CB Insights' Investor Mosaic's 2014 ranking of top 20 healthcare venture capital firms. These products received about $4 billion across 270 transactions. Biotechnology and drug development each garnered 20% of the money, while pharmaceuticals and drugs collected one-tenth of the venture capital.

This money is critical to deliver on their dreams, but many startup entrepreneurs envision changing the world through their technologies. "I participated in a few clinical trials myself and saw how they are currently conducted, even in the heart of Silicon Valley. There are still a lot of manual processes and heavy usage of paper, a lot of which results in the huge amount of time [15 years] and money [$1.8 billion] that's currently needed to take a drug to market," Avik Pal, founder and president of CliniOps, told InformationWeek.

Founding members of the 14-month-old firm, which wants to transform clinical trials, raised about $100,000, Pal said. "The clinical trial industry is at the point of inflection, and cutting-edge technology innovation leveraging social, mobile, analytics, and cloud can bring a paradigm shift in how the operations would be carried out. At CliniOps, we want to lead the transformation."

For its part, BridgeCrest saw the advent of wearables -- from traditional fitness bands to tattoos and emerging products -- and focused on capturing data from these devices for its infectious disease analytics solution, initially targeting Ebola. Likewise, startup Nanobiosym's Gene-Radar diagnostic technology can test for any disease -- such as Ebola, HIV/AIDS, or cancer -- via an iPad-size device, without requiring running water, a trained staff, or electricity.  

Other startups focus on the complexities of healthcare billing and invoicing, trying to reduce the errors and complexities associated with today's processes. Some tackle problems created by the system's growing reliance on electronic health records -- clinicians' decreased productivity, the flood of data, and patient frustrations, for example -- while others target patient compliance, population health, or improving overall wellness.

We've collected some of the helathcare startups worth watching. Who else would you include?

Alison Diana is an experienced technology, business and broadband editor and reporter. She has covered topics from artificial intelligence and smart homes to satellites and fiber optic cable, diversity and bullying in the workplace to measuring ROI and customer experience. An ... View Full Bio

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
1 of 11
Comment  | 
Print  | 
More Insights
Newest First  |  Oldest First  |  Threaded View
Bahati Pop
Bahati Pop,
User Rank: Apprentice
12/10/2016 | 12:04:26 PM
This is a great post. Now thinking about it, I need to buy health insurance for 2017. I live in Miami, Sunny Isles to be more precise. Has anyone worked with alltrustfl.com? Thank you
User Rank: Apprentice
1/20/2015 | 8:17:05 PM
health start ups cliche'd and misses point
So like the big pharma fallacy, the PR trolls will cite epic misinformation violating the AMA Code of Ethics to make sure the masses are completely misguided so they can stay sick to need these things.  So many of these "Cures" and the big hype on Obamacare is a big disaster in the first place.  It's HORRIBLE.  

I was exploited for $4000 and I caught the doctors red handed.  No tech, no drug would've spared me the trouble caused by a severe conflict of interest.  I am ready to pull their hair out.  

Some of these "start ups" are gimmicks.  I get the entire Blue Sky business where nepotism is encouraged for the right reasons, but in todays' market- nothing gets IPO'd unless it's already big.  So they're just getting their friends to buy them out.  

And we, taxpayers who helped fund the tech expansion for the techies only at our expense as consumers of a monopolized sector stuck in red tape are supposed to go along with innovation to benefit as an economy, consumer or healthcare provider.  So somebody with investors' money in a big firm can buy them out and make their friends rich.  

User Rank: Apprentice
1/6/2015 | 10:56:20 AM
End To End Solution
There are e2e solutions getting developed which will be more useful. Like device to collect data, analysis, automated personal recommendation and delivery of medcines. This is specfically useful for chronic diseases. I know a company called Cooey Technologies doing this out of India. Not sure it will be available in US from them for now. But a company to watch.
User Rank: Author
12/31/2014 | 1:01:52 AM
To our health!

It's a great list. I think the potential is tremendous for technology to attack contagious diseases and help those with chronic illnesses reduce crises. These companies all have interesting solutions that touch on these areas, I hope they are successful in their efforts for all our health! The challenge will be integrating all this technology into the existing infrastructures to become most effective and efficient.

User Rank: Ninja
12/29/2014 | 4:33:39 PM
I smell another bubble
With all the money being poured into healthcare startups that VCs, no doubt, consider easy money to be made, this is remniscent of the late 90s/early 2000s when the tech boom was in full swing.  Unfortunately, the dot com days soon turned into dot bomb once the big players made their money.  However, everyone else was left holding a pink slip and/or left with an empty bank account.  I don't see a meaningful difference between then vs now.  It's the same irrational exuberance all over again.
Samir Qamar MD
Samir Qamar MD,
User Rank: Apprentice
12/29/2014 | 2:11:15 PM
Thank you for recognizing MedWand. Our device is designed to move the entire telemedicine industry from consultations to actual, real-time examinations. In response to the point made in the article, we will absolutely be seeking the appropriate FDA clearances, a process that has already begun.

Samir Qamar

President, MedWand Solutions, Inc.
David F. Carr
David F. Carr,
User Rank: Author
12/29/2014 | 2:10:55 PM
Simple is good
The smart pill bottle strikes me as the most focused and useful of the products in this batch.
User Rank: Ninja
12/29/2014 | 11:57:29 AM
Neuro start up entrepenuers
In the Neuro startup challenge I would be interested to know how STEM researchers faired against entrepenuers in the later stages. Since getting venture capital depends on getting your message across so people want to spends on it, I'm wondering if the entrepenuers stastically beat out the STEM researchers for getting into the later rounds of the start up. Either way it looks like a steallar way for new healthcare ideas to get funded.
10 Ways to Transition Traditional IT Talent to Cloud Talent
Lisa Morgan, Freelance Writer,  11/23/2020
What Comes Next for the COVID-19 Computing Consortium
Joao-Pierre S. Ruth, Senior Writer,  11/24/2020
Top 10 Data and Analytics Trends for 2021
Jessica Davis, Senior Editor, Enterprise Apps,  11/13/2020
White Papers
Register for InformationWeek Newsletters
Current Issue
Why Chatbots Are So Popular Right Now
In this IT Trend Report, you will learn more about why chatbots are gaining traction within businesses, particularly while a pandemic is impacting the world.
Flash Poll